1417. Evaluating the Dissonance Between Cmax and AUC with Clinically Utilized Aminoglycoside (AG) Dosing Regimens: Use of Tobramycin (TOB) Against Pseudomonas aeruginosa (PA) as a Case Study
Author(s) -
Nikolas J. Onufrak,
Sujata M. Bhavnani,
Jason M. Pogue,
Christopher M. Rubino
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy210.1248
Subject(s) - cmin , cmax , medicine , renal function , dosing , pharmacokinetics , pharmacology , population , urology , tobramycin , pharmacodynamics , antibiotics , biology , microbiology and biotechnology , gentamicin , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom